Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?

被引：13

作者：

Amarenco, P

Donnan, GA

机构：

[1] Bichat Hosp & Med Sch, Paris, France

[2] Univ Melbourne, Parkville, Vic 3052, Australia

来源：

STROKE | 2004年 / 35卷 / 11期

关键词：

D O I：

10.1161/01.STR.0000145053.27085.66

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：2606 / 2608

页数：3

共 10 条

[1] Antithrombotic and thrombolytic therapy for ischemic stroke [J].

Albers, GW ;

Amarenco, P ;

Easton, JD ;

Sacco, RL ;

Teal, P .

CHEST, 2004, 126 (03) :483S-512S

[2] Combination therapy with clopidogrel and aspirin - Can the CURE results be extrapolated to cerebrovascular patients? [J].

Albers, GW ;

Amarenco, P .

STROKE, 2001, 32 (12) :2948-2949

[3] Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia [J].

Algra, A ;

vanGijn, J .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 60 (02) :197-199

[4]

Amarenco P, 1996, NEW ENGL J MED, V334, P1216

[5]

Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71

[6] Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial [J].

Diener, HC ;

Bogousslavsky, J ;

Brass, LM ;

Cimminiello, C ;

Csiba, L ;

Kaste, M ;

Leys, D ;

Matias-Guiv, J ;

Rupprecht, HJ .

LANCET, 2004, 364 (9431) :331-337

[7] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].

Gent, M ;

Beaumont, D ;

Blanchard, J ;

Bousser, MG ;

Coffman, J ;

Easton, JD ;

Hampton, JR ;

Harker, LA ;

Janzon, L ;

Kusmierek, JJE ;

Panak, E ;

Roberts, RS ;

Shannon, JS ;

Sicurella, J ;

Tognoni, G ;

Topol, EJ ;

Verstraete, M ;

Warlow, C .

LANCET, 1996, 348 (9038) :1329-1339

[8] Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke [J].

Macleod, MR ;

Amarenco, P ;

Davis, SM ;

Donnan, GA .

LANCET NEUROLOGY, 2004, 3 (07) :408-414

[9] Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial [J].

Steinhubl, SR ;

Berger, PB ;

Mann, JT ;

Fry, ETA ;

DeLago, A ;

Wilmer, C ;

Topol, EJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (19) :2411-2420

[10]

Yusuf S, 2001, NEW ENGL J MED, V345, P494

← 1 →